Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series
Journal of Pediatric Gastroenterology and Nutrition · 2025
DOI: 10.1002/jpn3.70227 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Georg-Friedrich Vogel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics I, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Liver Transplantation, Cholestasis, Intrahepatic, Diarrhea, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ipsen.
Abstract (Originalsprache)
Objectives
Patients with progressive familial intrahepatic cholestasis type 1 (PFIC1) who have undergone liver transplantation (LT) may have unmet needs and impacts on daily life due to post‐LT complications, including diarrhea and hepatic steatosis. Here, we describe the effects of the ileal bile acid transporter inhibitor odevixibat on diarrhea and hepatic steatosis in a cohort of patients with PFIC1 post‐LT.
Methods
Treating physicians from six centers retrospectively collected data through July 2023 on patients with PFIC1 who received odevixibat post‐LT. Data collected included demographics, medical history, and symptom presentation, characteristics of diarrhea, and liver imaging and/or histopathology.
Results
Overall, nine male patients with PFIC1 (seven aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
- Institute of Cell Biology, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Pediatric Gastroenterology, Transplant Medicine, University Children's Hospital, Essen, Germany.
- Hepatology and Liver Transplantation Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Pediatric Gastroenterology/Hepatology, Department of Pediatrics, University of Groningen, Beatrix Children's Hospital/University Medical Center Groningen, Groningen, the Netherlands.
- Université Catholique de Louvain, Cliniques St Luc, Brussels, Belgium.
ORCID-Profile: Elke Lainka
Förderung
- Ipsen
Zitieren
APA
Vogel, G. F., Kathemann, S., Pietrobattista, A., Maggiore, G., Aldrian, D., Sciveres, M., Verkade, H. J., Sokal, E., Jannone, G., Salcedo, M., Rauschkolb, P., Maucksch, C., Valcheva, V., & Lainka, E. (2025). Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70227
Vancouver
Vogel GF, Kathemann S, Pietrobattista A, Maggiore G, Aldrian D, Sciveres M, et al. Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70227
BibTeX
@article{Vogel2025,
author = {Vogel, Georg-Friedrich and Kathemann, Simone and Pietrobattista, Andrea and Maggiore, Giuseppe and Aldrian, Denise and Sciveres, Marco and Verkade, Henkjan J and Sokal, Etienne and Jannone, Giulia and Salcedo, Magdalena and Rauschkolb, Peter and Maucksch, Christof and Valcheva, Velichka and Lainka, Elke},
title = {Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
doi = {10.1002/jpn3.70227}
}
EUVIMED